CRLVSNRSN• 28 Days (Normalized)
CRL vs NRSN (Charles River Laboratories International Inc. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Sep 8 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CRL Performance $304.96
+8.62%
Charles River Laboratories International Inc.
Normalized Baseline0.00%
NRSN Performance $4.07
+873.68%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-865.06 pts
NRSN outperforming by 865.06 percentage points
CRLNRSN
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CRL NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | CRL Price | CRL Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $304.96 | +8.62% | $4.07 | +873.68% | -865.06% |
| Oct 05, 2026 | $310.77 | +10.69% | $4.03 | +864.11% | -853.42% |
| Oct 02, 2026 | $290.19 | +3.36% | $3.94 | +841.39% | -838.03% |
| Oct 01, 2026 | $286.83 | +2.16% | $- | - | |
| Sep 30, 2026 | $295.01 | +5.08% | $- | - | |
| Sep 29, 2026 | $295.96 | +5.41% | $4.78 | +1043.54% | -1038.13% |
| Sep 28, 2026 | $294.59 | +4.93% | $5.10 | +1120.10% | -1115.17% |
| Sep 25, 2026 | $292.84 | +4.30% | $6.95 | +1562.68% | -1558.38% |
| Sep 24, 2026 | $- | $7.40 | +1670.33% | - | |
| Sep 23, 2026 | $277.33 | -1.22% | $7.40 | +1670.33% | -1671.55% |
| Sep 22, 2026 | $285.11 | +1.55% | $7.18 | +1617.70% | -1616.15% |
| Sep 21, 2026 | $279.01 | -0.62% | $6.62 | +1483.73% | -1484.35% |
| Sep 18, 2026 | $278.06 | -0.96% | $6.35 | +1419.14% | -1420.10% |
| Sep 17, 2026 | $281.67 | +0.32% | $6.72 | +1507.66% | -1507.34% |
| Sep 16, 2026 | $273.41 | -2.62% | $6.49 | +1452.63% | -1455.25% |
Page 1 of 2